CORT Corcept Therapeutics RESULTS: Q2, Q2 EPS $0.36, Q2 REV $256.147M, Q2 Net Income $42.987M
CORT Corcept Therapeutics RESULTS: Q2, Q2 EPS $0.36, Q2 REV $256.147M, Q2 Net Income $42.987M
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.